$PRPH
ProPhase Labs, Inc.

2014 Q2 Form 10-Q Financial Statement

#000114420414048848 Filed on August 12, 2014

View on sec.gov

Income Statement

Concept 2014 Q2 2013 Q2
Revenue $1.797M $1.939M
YoY Change -7.32% 2.38%
Cost Of Revenue $1.005M $1.011M
YoY Change -0.59% -5.43%
Gross Profit $792.0K $928.0K
YoY Change -14.66% 12.48%
Gross Profit Margin 44.07% 47.86%
Selling, General & Admin $3.656M $2.430M
YoY Change 50.45% 9.07%
% of Gross Profit 461.62% 261.85%
Research & Development $273.0K $216.0K
YoY Change 26.39% -59.17%
% of Gross Profit 34.47% 23.28%
Depreciation & Amortization $70.00K $60.00K
YoY Change 16.67% 0.0%
% of Gross Profit 8.84% 6.47%
Operating Expenses $3.929M $2.646M
YoY Change 48.49% -4.03%
Operating Profit -$3.137M -$1.718M
YoY Change 82.6% -11.08%
Interest Expense $2.000K $2.000K
YoY Change 0.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$3.138M -$1.719M
YoY Change 82.55% -10.93%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$3.138M -$1.719M
YoY Change 82.55% -10.93%
Net Earnings / Revenue -174.62% -88.65%
Basic Earnings Per Share -$0.19 -$0.11
Diluted Earnings Per Share -$0.19 -$0.11
COMMON SHARES
Basic Shares Outstanding 16.94K shares 15.85M shares
Diluted Shares Outstanding 16.94K shares 15.85K shares

Balance Sheet

Concept 2014 Q2 2013 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $7.350M $4.060M
YoY Change 81.03% -11.93%
Cash & Equivalents $7.350M $4.058M
Short-Term Investments
Other Short-Term Assets $730.0K $520.0K
YoY Change 40.38% 6.12%
Inventory $3.248M $3.289M
Prepaid Expenses
Receivables $2.343M $1.128M
Other Receivables $0.00 $0.00
Total Short-Term Assets $13.67M $8.995M
YoY Change 52.02% -2.02%
LONG-TERM ASSETS
Property, Plant & Equipment $2.509M $2.495M
YoY Change 0.56% 3.1%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $6.086M $6.072M
YoY Change 0.23% 1.2%
TOTAL ASSETS
Total Short-Term Assets $13.67M $8.995M
Total Long-Term Assets $6.086M $6.072M
Total Assets $19.76M $15.07M
YoY Change 31.15% -0.74%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.399M $1.027M
YoY Change 36.22% 93.77%
Accrued Expenses $3.080M $2.180M
YoY Change 41.28% -59.7%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $5.952M $4.471M
YoY Change 33.12% -30.14%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $200.0K $300.0K
YoY Change -33.33%
Total Long-Term Liabilities $200.0K $300.0K
YoY Change -33.33%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.952M $4.471M
Total Long-Term Liabilities $200.0K $300.0K
Total Liabilities $6.150M $4.771M
YoY Change 28.9% -25.45%
SHAREHOLDERS EQUITY
Retained Earnings -$9.327M -$7.219M
YoY Change 29.2%
Common Stock $48.57M $43.15M
YoY Change 12.56%
Preferred Stock
YoY Change
Treasury Stock (at cost) $25.64M $25.64M
YoY Change 0.0%
Treasury Stock Shares 5.336M shares 5.336M shares
Shareholders Equity $13.61M $10.30M
YoY Change
Total Liabilities & Shareholders Equity $19.76M $15.07M
YoY Change 31.15% -0.74%

Cashflow Statement

Concept 2014 Q2 2013 Q2
OPERATING ACTIVITIES
Net Income -$3.138M -$1.719M
YoY Change 82.55% -10.93%
Depreciation, Depletion And Amortization $70.00K $60.00K
YoY Change 16.67% 0.0%
Cash From Operating Activities -$1.990M -$240.0K
YoY Change 729.17% -83.78%
INVESTING ACTIVITIES
Capital Expenditures -$60.00K -$240.0K
YoY Change -75.0% 33.33%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$60.00K -$240.0K
YoY Change -75.0% 33.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 3.880M 0.000
YoY Change
NET CHANGE
Cash From Operating Activities -1.990M -240.0K
Cash From Investing Activities -60.00K -240.0K
Cash From Financing Activities 3.880M 0.000
Net Change In Cash 1.830M -480.0K
YoY Change -481.25% -71.08%
FREE CASH FLOW
Cash From Operating Activities -$1.990M -$240.0K
Capital Expenditures -$60.00K -$240.0K
Free Cash Flow -$1.930M $0.00
YoY Change -663142950502400300.0% -100.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2564000 USD
CY2014Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3577000 USD
CY2014Q2 us-gaap Cash Uninsured Amount
CashUninsuredAmount
6900000 USD
CY2014Q2 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
1500000 USD
CY2014Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1700000 USD
CY2014Q2 us-gaap Due From Banks
DueFromBanks
7600000 USD
CY2013Q4 prph Prepaid Advertising And Incentive Promotions
PrepaidAdvertisingAndIncentivePromotions
1300000 USD
CY2014Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0005
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
4400000 USD
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
4500000 USD
CY2013Q2 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
527000 USD
CY2014Q2 prph Prepaid Advertising And Incentive Promotions
PrepaidAdvertisingAndIncentivePromotions
180000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
79000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
128000 USD
CY2014Q2 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
636000 USD
CY2013Q2 us-gaap Share Based Compensation
ShareBasedCompensation
40000 USD
CY2014Q2 us-gaap Share Based Compensation
ShareBasedCompensation
64000 USD
CY2014Q2 us-gaap Contractual Obligation Due In Next Twelve Months
ContractualObligationDueInNextTwelveMonths
641000 USD
CY2014Q2 us-gaap Contractual Obligation Due In Second Year
ContractualObligationDueInSecondYear
1140000 USD
CY2014Q2 us-gaap Contractual Obligation Due In Third Year
ContractualObligationDueInThirdYear
100000 USD
CY2014Q2 us-gaap Contractual Obligation Due In Fourth Year
ContractualObligationDueInFourthYear
0 USD
CY2014Q2 us-gaap Contractual Obligation Due In Fifth Year
ContractualObligationDueInFifthYear
0 USD
CY2014Q2 us-gaap Contractual Obligation
ContractualObligation
1881000 USD
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7350000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1638000 USD
CY2014Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2343000 USD
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5319000 USD
CY2014Q2 us-gaap Inventory Net
InventoryNet
3248000 USD
CY2013Q4 us-gaap Inventory Net
InventoryNet
2521000 USD
CY2014Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
733000 USD
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1801000 USD
CY2014Q2 us-gaap Assets Current
AssetsCurrent
13674000 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
11279000 USD
CY2014Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2509000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3577000 USD
CY2014Q2 us-gaap Assets
Assets
19760000 USD
CY2013Q4 us-gaap Assets
Assets
17420000 USD
CY2014Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1399000 USD
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1011000 USD
CY2014Q2 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
3078000 USD
CY2013Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
2847000 USD
CY2014Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1475000 USD
CY2013Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
766000 USD
CY2014Q2 us-gaap Liabilities Current
LiabilitiesCurrent
5952000 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4624000 USD
CY2014Q2 us-gaap Liabilities Other Than Longterm Debt Noncurrent
LiabilitiesOtherThanLongtermDebtNoncurrent
200000 USD
CY2013Q4 us-gaap Liabilities Other Than Longterm Debt Noncurrent
LiabilitiesOtherThanLongtermDebtNoncurrent
200000 USD
CY2014Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
CY2014Q2 us-gaap Common Stock Value
CommonStockValue
12000 USD
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
11000 USD
CY2014Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
48560000 USD
CY2013Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
43607000 USD
CY2014Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-9327000 USD
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5385000 USD
CY2014Q2 us-gaap Treasury Stock Value
TreasuryStockValue
25637000 USD
CY2013Q4 us-gaap Treasury Stock Value
TreasuryStockValue
25637000 USD
CY2014Q2 us-gaap Stockholders Equity
StockholdersEquity
13608000 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
12596000 USD
CY2014Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
19760000 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
17420000 USD
CY2012 us-gaap Payments For Legal Settlements
PaymentsForLegalSettlements
2100000 USD
CY2013 prph Settlement Benefit
SettlementBenefit
100000 USD
CY2013Q4 prph Additional Royalties And Commissions Accrual Interest Percentage
AdditionalRoyaltiesAndCommissionsAccrualInterestPercentage
0.0325 pure
CY2013 prph Additional Royalties And Commissions Payable Installment Amount
AdditionalRoyaltiesAndCommissionsPayableInstallmentAmount
100000 USD
CY2012Q4 prph Additional Royalties And Commissions Payable Installment Amount
AdditionalRoyaltiesAndCommissionsPayableInstallmentAmount
100000 USD
CY2014Q2 prph Additional Annual Installment Includes In Other Current Liability
AdditionalAnnualInstallmentIncludesInOtherCurrentLiability
100000 USD
CY2013Q4 prph Additional Annual Installment Includes In Other Long Term Obligation
AdditionalAnnualInstallmentIncludesInOtherLongTermObligation
200000 USD
CY2013 us-gaap Litigation Settlement Interest
LitigationSettlementInterest
13000 USD
prph Equity Method Investment Ownership Percentage Required For Rights Exercisable Under Right Agreement
EquityMethodInvestmentOwnershipPercentageRequiredForRightsExercisableUnderRightAgreement
0.15 pure
prph Cash Less Exercise Of Right Terms
CashLessExerciseOfRightTerms
In the event of a cashless exercise of the Right and the acquirer has acquired less than 50% beneficial ownership of the Company, a stockholder may exchange one Right for one common share of the Company.
prph Share Based Compensation Arrangement By Share Based Payment Option Expiration Terms
ShareBasedCompensationArrangementByShareBasedPaymentOptionExpirationTerms
No incentive stock option could be exercisable more than ten years after the date of grant or five years after the date of grant where the individual owns more than ten percent of the total combined voting power of all classes of stock. Stockholders approved the 1997 Plan in Fiscal 1998.
CY2010 prph Payments To Fund Joint Venture Investments
PaymentsToFundJointVentureInvestments
500000 USD
CY2010 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
3600000 USD
CY2010 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P12Y9M
CY2010 prph Ownership Percentage In Joint Venture
OwnershipPercentageInJointVenture
0.5 pure
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1429000 USD
CY2014Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16944 shares
CY2013Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2014Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.19
prph Dilutive Securities Options Earnings Per Share Value
DilutiveSecuritiesOptionsEarningsPerShareValue
0 USD
CY2013Q2 prph Dilutive Securities Options Earnings Per Share Value
DilutiveSecuritiesOptionsEarningsPerShareValue
0 USD
CY2014Q2 prph Dilutive Securities Options Earnings Per Share Value
DilutiveSecuritiesOptionsEarningsPerShareValue
0 USD
prph Dilutive Securities Options Earnings Share
DilutiveSecuritiesOptionsEarningsShare
0 shares
prph Dilutive Securities Options Earnings Share
DilutiveSecuritiesOptionsEarningsShare
0 shares
CY2013Q2 prph Dilutive Securities Options Earnings Share
DilutiveSecuritiesOptionsEarningsShare
0 shares
CY2014Q2 prph Dilutive Securities Options Earnings Share
DilutiveSecuritiesOptionsEarningsShare
0 shares
prph Dilutive Securities Options Earnings Per Share
DilutiveSecuritiesOptionsEarningsPerShare
0
prph Dilutive Securities Options Earnings Per Share
DilutiveSecuritiesOptionsEarningsPerShare
0
CY2013Q2 prph Dilutive Securities Options Earnings Per Share
DilutiveSecuritiesOptionsEarningsPerShare
0
CY2014Q2 prph Dilutive Securities Options Earnings Per Share
DilutiveSecuritiesOptionsEarningsPerShare
0
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-1429000 USD
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-3942000 USD
CY2013Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-1719000 USD
CY2014Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-3138000 USD
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15799 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16709 shares
CY2013Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15845 shares
CY2014Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16944 shares
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.09
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.24
CY2013Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
CY2014Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.19
CY2014Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4197000 USD
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4064000 USD
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0005
CY2014Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2014Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
24635266 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21437059 shares
CY2014Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
5336053 shares
CY2013Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
5336053 shares
us-gaap Sales Revenue Net
SalesRevenueNet
9481000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
7968000 USD
CY2013Q2 us-gaap Sales Revenue Net
SalesRevenueNet
1939000 USD
CY2014Q2 us-gaap Sales Revenue Net
SalesRevenueNet
1797000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3214000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3196000 USD
CY2013Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1011000 USD
CY2014Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1005000 USD
us-gaap Gross Profit
GrossProfit
6267000 USD
us-gaap Gross Profit
GrossProfit
4772000 USD
CY2013Q2 us-gaap Gross Profit
GrossProfit
928000 USD
CY2014Q2 us-gaap Gross Profit
GrossProfit
792000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4072000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3849000 USD
CY2013Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
709000 USD
CY2014Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
852000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3216000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4311000 USD
CY2013Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1721000 USD
CY2014Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2804000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
404000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
551000 USD
CY2013Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
216000 USD
CY2014Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
273000 USD
us-gaap Operating Expenses
OperatingExpenses
7692000 USD
us-gaap Operating Expenses
OperatingExpenses
8711000 USD
CY2013Q2 us-gaap Operating Expenses
OperatingExpenses
2646000 USD
CY2014Q2 us-gaap Operating Expenses
OperatingExpenses
3929000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-1425000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-3939000 USD
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1718000 USD
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3137000 USD
us-gaap Interest And Other Income
InterestAndOtherIncome
1000 USD
us-gaap Interest And Other Income
InterestAndOtherIncome
1000 USD
CY2013Q2 us-gaap Interest And Other Income
InterestAndOtherIncome
1000 USD
CY2014Q2 us-gaap Interest And Other Income
InterestAndOtherIncome
1000 USD
us-gaap Interest Expense
InterestExpense
5000 USD
us-gaap Interest Expense
InterestExpense
4000 USD
CY2013Q2 us-gaap Interest Expense
InterestExpense
2000 USD
CY2014Q2 us-gaap Interest Expense
InterestExpense
2000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1429000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3942000 USD
CY2013Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1719000 USD
CY2014Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3138000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2013Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2014Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Net Income Loss
NetIncomeLoss
-1429000 USD
us-gaap Net Income Loss
NetIncomeLoss
-3942000 USD
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
-1719000 USD
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
-3138000 USD
us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.09
us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.24
CY2013Q2 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.11
CY2014Q2 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.19
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
128000 USD
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
4826000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
120000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
133000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
79000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
128000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-4281000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2976000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1237000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
727000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-269000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
388000 USD
prph Increase Decrease In Accrued Marketing Costs
IncreaseDecreaseInAccruedMarketingCosts
-576000 USD
prph Increase Decrease In Accrued Marketing Costs
IncreaseDecreaseInAccruedMarketingCosts
231000 USD
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-2572000 USD
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-1777000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
964000 USD
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
195000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4826000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
195000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
4826000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
3486000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
5712000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
572000 USD
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4058000 USD
CY2014Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
45
dei Document Type
DocumentType
10-Q
dei Amendment Flag
AmendmentFlag
false
dei Document Period End Date
DocumentPeriodEndDate
2014-06-30
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Registrant Name
EntityRegistrantName
ProPhase Labs, Inc.
dei Entity Central Index Key
EntityCentralIndexKey
0000868278
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Trading Symbol
TradingSymbol
PRPH
CY2014Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
19299213 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
15799 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
16709 shares
CY2013Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
15845 shares
CY2014Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
16944 shares
prph Percentage Of Discount On Exercise Of Right
PercentageOfDiscountOnExerciseOfRight
0.5 pure
CY2013Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1301500 shares
CY2014Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1632500 shares

Files In Submission

Name View Source Status
0001144204-14-048848-index-headers.html Edgar Link pending
0001144204-14-048848-index.html Edgar Link pending
0001144204-14-048848.txt Edgar Link pending
0001144204-14-048848-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
prph-20140630.xml Edgar Link completed
prph-20140630.xsd Edgar Link pending
prph-20140630_cal.xml Edgar Link unprocessable
prph-20140630_def.xml Edgar Link unprocessable
prph-20140630_lab.xml Edgar Link unprocessable
prph-20140630_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v385647_10q.htm Edgar Link pending
v385647_ex31-1.htm Edgar Link pending
v385647_ex31-2.htm Edgar Link pending
v385647_ex32-1.htm Edgar Link pending
v385647_ex32-2.htm Edgar Link pending